History of Insulin Discovery

Author(s):  
Vsevolod Skvortsov

Insulin therapy is one of the most important methods of treating diabetes, and it is indispensable for type 1 diabetes. Thanks to insulin, diabetes has ceased to be a deadly disease, leading to death in a matter of months. For a number of years, until the discovery of insulin, diabetes was an almost incurable disease. Adherence to a strict diet with a restriction of carbohydrates was considered the only method of treatment, however, this diet led to the exhaustion of already weakened patients, and helped to prolong life for only a few years. Scientists from different countries unsuccessfully tried to solve this problem by conducting numerous experiments on animals, and only at the end of the 19th and beginning of the 20th centuries the hope of success appeared. In 1889, the famous scientist Oskar Minkowski (1858-1931) found that diabetes would certainly develop as a result of the removal of the dog’s pancreas. Thus, it became clear that the pancreas produces not only digestive enzymes, but also some other specific substance that prevents the development of diabetes. It took years to isolate this substance, first called ayletin, and subsequently insulin, and finally, in 1922, a long-awaited breakthrough happened in this area. In 1923, the Nobel Prize in the nomination "Medicine and Physiology" was awarded to two scientists - Frederick Banting and John Macleod, and humanity received the long-awaited cure from diabetes thanks to their discovery.

2019 ◽  
Vol 4 (2) ◽  
pp. 56-60
Author(s):  
Malihe Mohammadi ◽  
Seyedeh Solmaz Moosavi

Introduction: The association between the incidence of glutamic acid decarboxylase antibodies(GADAs) and risk of diabetes in pregnant women is controversial. Here, our aim was to investigate the incidence and clinical relevance of GADA and its association with development of post-delivery diabetes in women with gestational diabetes mellitus (GDM).Methods: This cohort study was conducted in Torbat–e Heydarieh (Khorasan Razavi, Iran) from October 2015 to March 2017. A total of 147 pregnant women with GDM were included in case group. The control group consisted of 147 healthy controls. A GAD diagnostic kit (Diametra Co.,Italy) was used for diagnosis of GADA. The history of insulin therapy and the development of diabetes one year after delivery were investigated.Results: Of 147 pregnant women with GDM, 9 (6.1%) had GADA in their sera. 14.3% (21 out of 147) of women with GDM had history of insulin therapy. 33.3% (7 of 21) of women who had received insulin developed diabetes one year after delivery. Type 1 and type 2 diabetes were observed in, respectively, 1 (0.7%) and 7 (4.8%) of women with GDM at one year after delivery.At one year after delivery, no women in GADA negative women was diagnosed with type 1 diabetes. However, type 2 diabetes was observed in 2.9% of GADA negative pregnant women.Type 1 and type 2 diabetes were also noticed in, respectively, 11.1% and 33.3% of GADA positive mothers at one year after delivery.Conclusion: The prevalence of GADA was 6.1% in diabetic pregnant women. The GADA positivity and history of insulin therapy during pregnancy were significant risk factors for diabetes at one year after delivery. In addition, development of type 1 diabetes was higher in GADA positive pregnant women with GDM than GADA negative women.


Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1129-P
Author(s):  
ANNE L. PETERS ◽  
THOMAS DANNE ◽  
SANGEETA SAWHNEY ◽  
PHILLIP L. BANKS ◽  
MICHAEL J. DAVIES ◽  
...  

2021 ◽  
Vol 9 (1) ◽  
pp. e002099
Author(s):  
Yuji Komorita ◽  
Masae Minami ◽  
Yasutaka Maeda ◽  
Rie Yoshioka ◽  
Toshiaki Ohkuma ◽  
...  

IntroductionType 1 diabetes (T1D) is associated with higher fracture risk. However, few studies have investigated the relationship between severe hypoglycemia and fracture risk in patients with T1D, and the results are controversial. Besides, none has investigated the risk factors for fracture in Asian patients with T1D. The aim of the present study was to investigate the prevalence of bone fracture and its relationship between severe hypoglycemia and other risk factors in Japanese patients with T1D.Research design and methodsThe single-center cross-sectional study enrolled 388 Japanese patients with T1D (mean age, 45.2 years; women, 60.4%; mean duration of diabetes, 16.6 years) between October 2019 and April 2020. The occurrence and circumstances of any fracture after the diagnosis of T1D were identified using a self-administered questionnaire. The main outcomes were any anatomic site of fracture and fall-related fracture. Severe hypoglycemia was defined as an episode of hypoglycemia that required the assistance of others to achieve recovery.ResultsA total of 92 fractures occurred in 64 patients, and 59 fractures (64%) were fall-related. Only one participant experienced fracture within the 10 years following their diagnosis of diabetes. In logistic regression analysis, the multivariate-adjusted ORs (95% CIs) of a history of severe hypoglycemia were 2.11 (1.11 to 4.09) for any fracture and 1.91 (0.93 to 4.02) for fall-related fracture. Fourteen of 18 participants with multiple episodes of any type of fracture had a history of severe hypoglycemia (p<0.001 vs no fracture).ConclusionsWe have shown that a history of severe hypoglycemia is significantly associated with a higher risk of bone fracture in Japanese patients with T1D.


2015 ◽  
Vol 52 (5) ◽  
pp. 1003-1006 ◽  
Author(s):  
Gianluca Tornese ◽  
Veronica Tisato ◽  
Lorenzo Monasta ◽  
Liza Vecchi Brumatti ◽  
Giorgio Zauli ◽  
...  

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 147-OR
Author(s):  
ELENA TOSCHI ◽  
CHRISTINE SLYNE ◽  
ASTRID ATAKOV-CASTILLO ◽  
MEDHA MUNSHI

Sign in / Sign up

Export Citation Format

Share Document